(Q39097387)

9 September 2017

title

A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice (English)

1 reference

9 September 2017

0 references

6

Mayling Alvarez

1 reference

9 September 2017

Alienys Izquierdo

1

1 reference

9 September 2017

Angélica García

2

1 reference

9 September 2017

Laura Lazo

3

1 reference

9 September 2017

Lázaro Gil

4

1 reference

9 September 2017

Ernesto Marcos

5

1 reference

9 September 2017

Iris Valdés

7

1 reference

9 September 2017

Lisset Hermida

8

1 reference

9 September 2017

Gerardo Guillén

9

1 reference

9 September 2017

María G Guzmán

10

1 reference

9 September 2017

language of work or name

1 reference

20 May 2014

1 reference

9 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Archives of Virology

1 reference

9 September 2017

volume

159

1 reference

9 September 2017

issue

10

1 reference

9 September 2017

page(s)

2597-2604

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

9 September 2017

1 reference

Antibody-enhanced dengue virus infection in primate leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Dengue vaccines: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

A fragment of the envelope protein from dengue-1 virus, fused in two different sites of the meningococcal P64k protein carrier, induces a functional immune response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

A dengue-2 Envelope fragment inserted within the structure of the P64k meningococcal protein carrier enables a functional immune response against the virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

The fusion site of envelope fragments from each serotype of Dengue virus in the P64k protein, influence some parameters of the resulting chimeric constructs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Carboxy-terminally truncated Dengue 4 virus envelope glycoprotein expressed in Pichia pastoris induced neutralizing antibodies and resistance to Dengue 4 virus challenge in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Invited commentary: Dengue lessons from Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Towards a dengue vaccine: progress to date and remaining challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Virus-specific CD8+ T cells in the liver: armed and ready to kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Immunological memory to viral infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Prolonged presence of effector-memory CD8 T cells in the central nervous system after dengue virus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

A recombinant capsid protein from Dengue-2 induces protection in mice against homologous virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Domain III of the envelope protein as a dengue vaccine target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2115-2

10.1007/S00705-014-2115-2

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference